| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2001;103:335.)
© 2001 American Heart Association, Inc.
AHA Scientific Statement |
Kawasaki disease, or
mucocutaneous lymph node syndrome, is a disease of unknown etiology
that most frequently (80% of the time) affects infants and children
under 5 years of age. Accurate diagnosis and early therapeutic
interventions such as aspirin and intravenous
-globulin can decrease
the approximately 20% risk of developing coronary artery
abnormalities. A specific diagnostic test does not exist. Thus,
diagnosis of Kawasaki disease is based on characteristic clinical signs
and symptoms, which are classified as principal clinical findings and
other clinical and laboratory findings. The male-to-female ratio among
patients with Kawasaki disease is 1.5:1. Children of nearly all
racial backgrounds are affected. Recurrences and cases in siblings are
seen only occasionally.
Principal Clinical Findings*
Fever persisting at least 5 days
and the presence of
at least 4 of the following 5 principal features:
1.5 cm in diameter), usually
unilateral *Patients with fever and fewer than 4 principal symptoms can be diagnosed as having Kawasaki disease when coronary artery disease is detected by 2-dimensional echocardiography or coronary angiography. Other diagnoses should be excluded. The physician should be aware that some children with illness not fulfilling these criteria have developed coronary artery aneurysms.
Many experts believe that in the presence of classic features, the
diagnosis of Kawasaki disease can be made by experienced observers
before day 5 of fever.
Other Significant Clinical and Laboratory Findings
Cardiovascular: On auscultation, gallop rhythm or distant heart sounds; ECG changes (arrhythmias, abnormal Q waves, prolonged PR and/or QT intervals, occasionally low voltage, or ST-Twave changes); chest x-ray abnormalities (cardiomegaly); echocardiographic changes (pericardial effusion, coronary aneurysms, or decreased contractility); mitral and/or aortic valvular insufficiency; and rarely, aneurysms of peripheral arteries (eg, axillary), angina pectoris, or myocardial infarction
Gastrointestinal: Diarrhea, vomiting, abdominal pain, hydrops of gallbladder, paralytic ileus, mild jaundice, and mild increase of serum transaminase levels
Blood: Increased erythrocyte sedimentation rate, leukocytosis with left shift, positive C-reactive protein, hypoalbuminemia, and mild anemia in acute phase of illness (thrombocytosis in subacute phase)
Urine: Sterile pyuria of urethral origin and occasional proteinuria
Skin: Perineal rash and desquamation in subacute phase and transverse furrows of fingernails (Beaus lines) during convalescence
Respiratory: Cough, rhinorrhea, and pulmonary infiltrate
Joint: Arthralgia and arthritis
Neurological: Mononuclear pleocytosis in cerebrospinal fluid, striking irritability, and rarely, facial palsy
Selected Readings
Newburger JW, Takahashi M, Beiser AS, et al. A single intravenous infusion of gamma globulin compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med. 1991;324:16331639.
Dajani AS, Taubert KA, Gerber MA, et al. Diagnosis and management of Kawasaki disease in children. Circulation. 1993;87:17761780.
Taubert KA, Rowley AH, Shulman ST. Seven-year national survey of Kawasaki disease and acute rheumatic fever. Pediatr Infect Dis J. 1994;13:704708.
Dajani AS, Taubert KA, Takahashi M, et al. Guidelines for long-term management of patients with Kawasaki disease: report from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 1994;89:916922.
Shulman ST, Rowley AH. Kawasaki syndrome. In: Jensen HB, Baltimore RS, eds. Pediatric Infectious Diseases: Principles and Practice. Norwalk, Conn: Appleton & Lange; 1995:629638.
Kato H, ed. Kawasaki Disease: Proceedings of the 5th International Kawasaki Disease Symposium, Fukuoka, Japan. Amsterdam: Elsevier; 1995.
Yanagawa H, Nakamura Y, Yashiro M, et al. Update of the epidemiology of Kawasaki disease in Japan: from the results of 199394 nationwide survey. J Epidemiol. 1996;6:148157.
Kato H, Sugimura T, Akagi T, et al. Long-term consequences of Kawasaki disease: a 10- to 21-year follow-up study of 594 patients. Circulation. 1996;94:13791385.
Shulman ST, Rowley AH. Etiology and pathogenesis of Kawasaki disease. Prog Pediatr Cardiol. 1997;6:187192.
Taubert KA. Epidemiology of Kawasaki disease in the United States and worldwide. Prog Pediatr Cardiol. 1997;6:181185.
Taubert KA, Shulman ST. Kawasaki disease. Am Fam Phys. 1999;57:30933102.
Barron KS, Shulman ST, Rowley A, et al. Report of the National Institutes of Health workshop on Kawasaki disease. J Rheumatol. 1999;26:170190.
|
|
|
|
|
|
Footnotes
For reprint requests, contact ktaubert@heart.org.
Adapted in part from the Japan Kawasaki Disease Research Committee.
This article has been cited by other articles:
![]() |
G. Simonini, C. D. Rose, A. Vierucci, F. Falcini, and B. H. Athreya Diagnosing Kawasaki syndrome: the need for a new clinical tool Rheumatology, August 1, 2005; 44(8): 959 - 961. [Full Text] [PDF] |
||||
![]() |
M. S. Anderson, J. K. Todd, and M. P. Glode Delayed Diagnosis of Kawasaki Syndrome: An Analysis of the Problem Pediatrics, April 1, 2005; 115(4): e428 - e433. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Falcini Vascular and connective tissue diseases in the paediatric world Lupus, February 1, 2004; 13(2): 77 - 84. [Abstract] [PDF] |
||||
![]() |
F Falcini, G Simonini, G B. Calabri, and R Cimaz Multifocal lymphadenopathy associated with severe Kawasaki disease: a difficult diagnosis Ann Rheum Dis, July 1, 2003; 62(7): 688 - 689. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |